Minitran and Ventolin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Minitran and Ventolin. Common interactions include angina pectoris among females and angina pectoris among males.

The phase IV clinical study analyzes what interactions people who take Minitran and Ventolin have. It is created by eHealthMe based on reports of 12 people who take Minitran and Ventolin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 27, 2022

12 people who take Minitran and Ventolin together, and have interactions are studied.


What is Minitran?

Minitran has active ingredients of nitroglycerin. eHealthMe is studying from 911 Minitran users for its effectiveness, alternative drugs and more.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,686 Ventolin users for its effectiveness, alternative drugs and more.

Number of Minitran and Ventolin reports submitted per year:

Minitran and Ventolin drug interactions.

Common Minitran and Ventolin drug interactions by gender *:

female:

  1. Angina pectoris
  2. Arrhythmia
  3. Bladder cancer
  4. Cardiac failure congestive
  5. Depressed level of consciousness
  6. Emotional distress
  7. Myocardial infarction
  8. Abdominal pain upper
  9. Altered state of consciousness
  10. Chest pain

male:

  1. Angina pectoris
  2. Atrial flutter

Common Minitran and Ventolin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Angina pectoris
  2. Anhedonia
  3. Bladder cancer
  4. Cardiac failure congestive
  5. Depressed level of consciousness
  6. Emotional distress
  7. Myocardial infarction
  8. Altered state of consciousness
  9. Atrial flutter
  10. Haematuria

Common conditions people have *:

  1. High Blood Pressure: 2 people, 16.67%
  2. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 16.67%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 16.67%
  4. Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 8.33%
  6. Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 1 person, 8.33%
  7. Intention Tremor (brain tremor): 1 person, 8.33%
  8. Incontinence (lack of moderation or self-control): 1 person, 8.33%
  9. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 8.33%
  10. Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Minitran and Ventolin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Minitran and Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Minitran interactions:

Browse all interactions between Minitran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ventolin interactions:

Browse all interactions between Ventolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin and albuterol (the active ingredients of Minitran and Ventolin, respectively), and Minitran and Ventolin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Minitran and Ventolin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: